ClassID:

20550

A61K31/727 - page 4 - CPC Classification

Classification description:

Medicinal preparations containing organic active ingredients; Carbohydrates; Sugars; Derivatives thereof; Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters; Glycosaminoglycans, i.e. mucopolysaccharides Heparin; Heparan

Recent Application in this class:
#901
20060257491
2006-11-16

Dry powder composition comprising co-jet milled particles for pulmonary inhalation

#902
20060251705
2006-11-09

Delivery of tigecycline in the presence of heparin

#903
20060240110
2006-10-26

Multifunctional and biologically active matrices from multicomponent polymeric solutions

#904
20060235503
2006-10-19

Local drug delivery devices and methods for maintaining the drug coatings thereon

#905
20060229276
2006-10-12

Use of glycosoaminoglycans for the prevention and treatment of sepsis

#906
20060228391
2006-10-12

Methods of tissue repair and compositions therefor

#907
20060228306
2006-10-12

Combination antihistamine and steroid medication

#908
20060222756
2006-10-05

Medical devices, drug coatings and methods of maintaining the drug coatings thereon

#909
20060210548
2006-09-21

Method for reducing obstructive hydrocephalus

#910
20060210532
2006-09-21

Means and methods for the recruitment and identification of stem cells

#911
20060204596
2006-09-14

Formulation of a mixture of Free-B-Ring flavonoids and flavans as a therapeutic agent

#912
20060198897
2006-09-07

Polycationic peptide coatings and methods of coating implantable medical devices

#913
20060198836
2006-09-07

Method of treating hit patients with argatroban

#914
20060194192
2006-08-31

Stabilization of cells and biological specimens for analysis

#915
20060193893
2006-08-31

Medical devices

#916
20060189571
2006-08-24

Use of lipid conjugates in the treatment of infection

#917
20060189570
2006-08-24

Use of lipid conjugates in the treatment of infection

#918
20060189569
2006-08-24

Use of lipid conjugates in the treatment of infection

#919
20060189568
2006-08-24

Use of lipid conjugates in the treatment of infection

#920
20060183712
2006-08-17

Affinity purified heparin/heparan sulfate for controlling the biological activity of the FGF receptor

#921
20060172968
2006-08-03

Derivatives of partially desulphated glycosaminoglycans as heparanase inhibitors, endowed with antiangiogenic activity and devoid of anticoagulating effect

#922
20060172967
2006-08-03

Method for producing alkyl-esterified glycosaminoglycan

#923
20060172008
2006-08-03

Freeze-dried fibrin matrices and methods for preparation thereof

#924
20060171899
2006-08-03

Water-stabilized aerosol formulation system and method of making

#925
20060167110
2006-07-27

Methods for treating cerebrovascular disease by administering desmethylselegiline

#926
20060166927
2006-07-27

Compounds that bind to the interferon-gamma, preparation method thereof and medicaments containing same

#927
20060166859
2006-07-27

Compounds and compositions for delivering active agents

#928
20060165780
2006-07-27

Anticoagulant composition

#929
20060159665
2006-07-20

Seed tear resistant scaffold

#930
20060154894
2006-07-13

Biologically active surfaces and methods of their use

#931
20060147547
2006-07-06

Bone enhancing composite

#932
20060147539
2006-07-06

Nanoparticles for protein drug delivery

#933
20060134130
2006-06-22

Oral drug delivery compositions and methods

#934
20060128657
2006-06-15

Selected betaines and their uses

#935
20060122152
2006-06-08

Heparin for the treatment of ocular pathologies

#936
20060121086
2006-06-08

Drug-eluting stents coated with non-nucleotide P2Yreceptor antagonist compound

#937
20060116350
2006-06-01

Method of increasing gastric emptying

#938
20060115457
2006-06-01

Biocompatible hydrogel compositions

#939
20060106110
2006-05-18

Modified amino acid for the inhibition of platelet aggregation

#940
20060105988
2006-05-18

Antipruritic composition for external use on skin

#941
20060100175
2006-05-11

Novel therapeutic use of low molecular weight heparins

#942
20060094690
2006-05-04

Antimicrobial locking solutions comprising taurinamide derivatives and biologically acceptable salts and acids, with the addition of small concentrations of heparin

#943
20060084631
2006-04-20

Antimicrobial charged polymers that exhibit resistance to lysosomal degradation during kidney filtration and renal passage, compositions and method of use thereof

#944
20060084593
2006-04-20

Anti-HIV composition, production method thereof and medicament

#945
20060083711
2006-04-20

Methods and products related to the intracellular delivery of polysaccharides

#946
20060079485
2006-04-13

Use of lipid conjugates in the treatment of infection

#947
20060079483
2006-04-13

Orthogonally protected disaccharide building blocks for synthesis of heparin oligosaccharides

#948
20060074049
2006-04-06

Use of heparinoids for treatment and prevention of dementia

#949
20060073210
2006-04-06

Nanoparticles for paracellular drug delivery

#950
20060073207
2006-04-06

Protein biomaterials and biocoacervates and methods of making and using thereof

#951
20060069044
2006-03-30

Modified glycosaminoglycans, pharmaceutical compositions and methods for oral delivery thereof

#952
20060067927
2006-03-30

Methods and compositions related to the modulation of intercellular junctions

#953
20060062768
2006-03-23

Biocompatible hydrogel compositions

#954
20060051319
2006-03-09

Neuroprotective effect of solubilized UDCA in focal ischemic model

#955
20060040896
2006-02-23

Method and medicament for anticoagulation using a sulfated polysaccharide with enhanced anti-inflammatory activity

#956
20060039950
2006-02-23

Multi-functional biocompatible coatings for intravascular devices

#957
20060035828
2006-02-16

Method of reducing viral load

#958
20060029578
2006-02-09

Composition and method for the repair and regeneration of cartilage and other tissues

#959
20060024664
2006-02-02

Methods and products related to evaluating the quality of a polysaccharide

#960
20060018944
2006-01-26

Polycationic peptide coatings and methods of coating implantable medical devices

#961
20060018894
2006-01-26

Administration of enoxoparin sodium to patients 75 years and older with ST-segment elevation myocardial infarction

#962
20060014720
2006-01-19

Heparin prodrugs and drug delivery stents formed therefrom

#963
20060014718
2006-01-19

Epimerized derivatives of K5 polysaccharide with a very high degree of sulfation

#964
20060008530
2006-01-12

Matrix made of polyester polymers entangled with hyaluronic polymers useful for supporting tissue repair

#965
20060002974
2006-01-05

Polycationic peptide coatings and methods of coating implantable medical devices

#966
20050288252
2005-12-29

Composition for stimulating bone growth and differentiation and method for isolating same

#967
20050288251
2005-12-29

Treatment and prevention of abnormal cellular proliferation

#968
20050287145
2005-12-29

Compositions and methods for producing vascular occlusion

#969
20050282775
2005-12-22

Method and medicament for sulfated polysaccharide treatment of inflammation without inducing platelet activation and heparin-induced thrombocytopenia syndrome

#970
20050282771
2005-12-22

Methods for treating bleeding disorders using sulfated polysaccharides

#971
20050277617
2005-12-15

Drugs against articular failure

#972
20050267134
2005-12-01

Non-nucleotide composition and method for inhibiting platelet aggregation

#973
20050256079
2005-11-17

Process for the manufacture of n-acyl-(epi)k5-amine-o-sulfate-derivatives and products thus obtained

#974
20050255162
2005-11-17

Hydrophobic biomolecular structure

#975
20050255138
2005-11-17

Active agent transport systems

#976
20050245736
2005-11-03

Low molecular weight oversulfated polysaccharide

#977
20050244363
2005-11-03

Hyaluronic acid based copolymers

#978
20050238702
2005-10-27

Medical composition containing photocrosslinkable chitosan derivative

#979
20050234015
2005-10-20

Low molecular weight heparin salt with triethanolamine useful as therapeutic-antitrombotic agent of local delivery, procedures for preparing them, process for elimination of hygroscopicity of heparin salt, pharmaceutical compositions for local use in antithrombotic therapy and uses therein

#980
20050234013
2005-10-20

Interstitial therapy for immediate symptom relief and chronic therapy in interstitial cystitis

#981
20050233005
2005-10-20

Use of glycosaminoglycans and zinc derivatives for insect bites, stings and the like

#982
20050232981
2005-10-20

Compositions capable of facilitating penetration across a biological barrier

#983
20050232970
2005-10-20

Process and systems for biocompatible surfaces

#984
20050227921
2005-10-13

Inhibition of FGF signaling

#985
20050215518
2005-09-29

Glycosaminoglycans derived from K5 polysaccharide having high anticoagulant and antithrombotic activities and process for their preparation

#986
20050209188
2005-09-22

Methods using glycosaminoglycans for the treatment of nephropathy

#987
20050203055
2005-09-15

Cellulose sulfate and other sulfated polysaccharides to prevent and treat papilloma virus infection and other infections

#988
20050202078
2005-09-15

Vesicle-encapsulated corticosteroids for the treatment of cancer

#989
20050196425
2005-09-08

Positive modulator of bone morphogenic protein-2

#990
20050192252
2005-09-01

Administration of enoxaparin sodium to patients with severe renal impairment

#991
20050192226
2005-09-01

Method of preventing fibrin clots in pulmonary tissue through the use of aerosolized anticoagulants

#992
20050191333
2005-09-01

Drug eluting coatings for medical implants and methods of use

#993
20050187185
2005-08-25

Pharmaceutical applications of hyaluronic acid preparations

#994
20050186176
2005-08-25

Compounds and compositions for delivering active agents

#995
20050181353
2005-08-18

Stabilization of cells and biological specimens for analysis

#996
20050176678
2005-08-11

Compounds and method for coating surfaces in a haemocompatibe manner

#997
20050175669
2005-08-11

Highly lubricious hydrophilic coating utilizing dendrimers

#998
20050171055
2005-08-04

Compositions of polysaccharides derived from heparin, their preparation and pharmaceutical compositions containing them

#999
20050164985
2005-07-28

Therapeutic application of enoxaparin

#1000
20050159388
2005-07-21

Non-nucleotide compositions and method for inhibiting platelet aggregation

#1001
20050153930
2005-07-14

Inhibition of a novel calcium injury current that forms in nuerons during injury prevents neuronal cell death

#1002
20050148510
2005-07-07

Active hedgehog protein conjugate

#1003
20050147581
2005-07-07

Macromolecular drug complexes having improved stability and therapeutic use of the same

#1004
20050143342
2005-06-30

Cellulose sulfate and other sulfated polysaccharides to prevent and treat papilloma virus infection and other infections

#1005
20050143298
2005-06-30

Angiogenically effective unit dose of FGF-2 and method of use

#1006
20050142202
2005-06-30

Compositions for achieving a therapeutic effect in an anatomical structure

#1007
20050142129
2005-06-30

Methods of preventing morbidity and mortality by perioperative administration of a blood clotting inhibitor

#1008
20050137167
2005-06-23

Derivatives of partially desulphated glycosaminoglycans as heparanase inhibitors, endowed with antiangiogenic activity and devoid of anticoagulating effect

#1009
20050123593
2005-06-09

Liposomal encapsulation of glycosaminoglycans for the treatment of arthritic joints

#1010
20050085478
2005-04-21

Compositions of a cyclooxygenase-2 selective inhibitor and a low-molecular-weight heparin for the treatment of central nervous system damage

#1011
20050080041
2005-04-14

Method and composition for the treatment of adenoviral ocular infections

#1012
20050079145
2005-04-14

Stabilized reverse micelle compositions and uses thereof

#1013
20050075314
2005-04-07

Use of sulfated glycosaminoglycans for establishing effective labor in women

#1014
20050065165
2005-03-24

Method of treating certain cancers using an estrogen agonist/antagonist

#1015
20050058702
2005-03-17

Compositions capable of facilitating penetration across a biological barrier

#1016
20050054600
2005-03-10

Modified protein kinase a-specific oligonucleotides and methods of their use

#1017
20050048101
2005-03-03

Plaster for topical use containing heparin and diclofenac

#1018
20050043273
2005-02-24

Compositions and methods for inhibiting slit protein and glypican interactions

#1019
20050043271
2005-02-24

Heparin-containing ophthalmic agent

#1020
20050033261
2005-02-10

Drug/drug delivery systems for the prevention and treatment of vascular disease

#1021
20050032745
2005-02-10

Modified low molecular weight heparin that inhibits clot associated coagulation factors

#1022
20050025846
2005-02-03

Pharmaceutical composition of complex carbohydrates and essential oils and methods of using the same

#1023
20050013867
2005-01-20

Use of proton sequestering agents in drug formulations

#1024
20050009782
2005-01-13

Antiviral charged polymers that exhibit resistance to lysosomal degradation during kidney filtration and renal passage, compositions and methods of use thereof

#1025
20050004663
2005-01-06

Heparin barrier coating for controlled drug release

#1026
20050002986
2005-01-06

Drug/drug delivery systems for the prevention and treatment of vascular disease

#1027
17970160
2023-08-22

Kit and new method of treatment for skin basal cell and squamous cell carcinoma

#1028
17573503
2024-03-26

Compositions and methods for prevention and treatment of coronavirus and related disorders

#1029
15378081
2017-10-24

Topical transdermal method for delivering nutrients through the skin for expedited wound healing and skin rejuvenation

#1030
13552920
2017-01-24

Topical transdermal method for delivering nutrients through the skin for expedited wound healing and skin rejuvination